Transcriptomic Profiling Identifies DCBLD2 as a Diagnostic and Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
Background: Accumulating evidence shows that the elevated expression of DCBLD2 (discoidin, CUB and LCCL domain-containing protein 2) is associated with unfavorable prognosis of various cancers. However, the correlation of DCBLD2 expression value with the diagnosis and prognosis of pancreatic ductal...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2021-03-01
|
| Col·lecció: | Frontiers in Molecular Biosciences |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fmolb.2021.659168/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|